in silico prediction
of new drug efficacy

Novadiscovery builds knowledge-driven models applied to virtual patients
and runs in silico clinical trials to de-risk and optimize R&D.

We help biotech and pharma companies sort through target combinations
in drug discovery, optimize the design of future clinical trials (best regimen,
optimal responders…), and assist with the value demonstration efforts
in market access.

Who we are


Worldwide experts from academia and industry endorsing Novadiscovery’s approach.

What we do

Discovery collaborations

For streamlined target identification & secured proof of concept.

What we do

Clinical insights & strategy

A digital sandbox to optimize trial design and capture best responders.

How we do it

The WISE engine

To ensure full traceability from a simulation output back to each primary source and avoid the black box syndrome.

How we do it

The effect model

The result of decades of experience in clinical trials methodology, the Effect Model law has solved the main problem plaguing the development of in silico clinical trials: the paradigm of efficacy.


Join Nova

We’re constantly on the hunt for the most talented individuals in our industry. If you have a knack for the development of mathematical and computational models of biological systems or if you are a genius developer with a keen interest in working on a state-of-the-art platform, fill the application form.